Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFrom first question to prescription: how semaglutide is actually used
The route from curiosity to a semaglutide prescription
Most people arrive at semaglutide the same way. They read about it, wonder if it's for them, and want to know what the process involves before committing to anything. Here's the honest sequence.
First, you check whether it's even licensed for your situation. Semaglutide for weight management (Wegovy) is licensed for adults with a BMI of 30 or above, or 27 and above when there's a weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Thresholds sit 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. Second, you complete a consultation covering your health history, medicines and measurements. Third, a prescriber reviews it and decides whether treatment is appropriate. Only then does a pharmacy dispense anything.
At nume this runs through our own GPhC-registered pharmacy. Your answers land on a named prescriber's desk, not in a queue for software, and the review happens the same day. We verify your identity with photo ID and confirm your weight on video, which is a safeguard rather than a hurdle. You can check any online pharmacy yourself on the General Pharmaceutical Council register before you hand over a penny.
The point of spelling this out is simple. There is no legal shortcut around clinical assessment for a medicine like this, and anyone offering one is a red flag rather than a bargain. If you want to see the treatments and how the consultation opens, our weight-loss treatment options lay it out plainly.
What semaglutide actually does inside the body
Semaglutide copies a hormone your gut already makes after eating, called glucagon-like peptide-1. Your body releases GLP-1 to signal fullness and to help manage blood sugar. Semaglutide binds to the same receptors, but it lasts far longer than the natural version, which is why the weight-loss injection is taken just once a week.
Three things follow from that. Your stomach empties more slowly, so food stays with you longer and you feel satisfied sooner. Appetite signalling in the brain shifts, so the constant background pull towards food, what many patients describe as "food noise", tends to quieten. And blood-sugar control improves, which is why the same molecule is also used in diabetes care under a different brand.
None of this makes weight simply fall off on its own. Semaglutide reduces how much you want to eat; it doesn't decide what you eat. That's why the licence always pairs it with a reduced-calorie diet and more movement. Getting enough protein, staying hydrated and keeping some strength activity going matter more once appetite drops, because eating too little of the right things is a real risk when hunger fades.
If you want the mechanism in more detail, we've written it up in how semaglutide works and, from the brand angle, in how Wegovy works for weight loss. The NHS medicines guide to semaglutide is a solid plain-English starting point too.
Wegovy, Ozempic and Rybelsus: why the same drug has different names
This is a question our prescribers hear most weeks, and the confusion is understandable. Semaglutide is the active ingredient in three different products, and they are not interchangeable in the eyes of UK licensing.
Wegovy is semaglutide licensed for weight management. Ozempic is semaglutide licensed for type 2 diabetes, not weight loss. Rybelsus is oral semaglutide, again licensed for type 2 diabetes. So although Ozempic contains exactly the same molecule as Wegovy, it is not a weight-loss medicine in UK law, and it shouldn't be presented or obtained as one. We unpack this properly in whether Wegovy is the same as Ozempic.
There's now a fourth member of the family worth knowing about. In June 2026 the MHRA approved Wegovy tablets, oral semaglutide for weight management, making the UK the first country in Europe to license an oral GLP-1 for this purpose. That's a genuinely new option for people who'd rather not inject, and we cover it in whether semaglutide can be taken orally.
The practical upshot: when you read "best semaglutide" content online, it usually just means "which semaglutide product is right for me", and the honest answer is that it depends on your health picture and whether you're being treated for weight or diabetes. The one made by Novo Nordisk for weight loss is Wegovy, and you can read who makes it on our page about the company behind Wegovy.
How semaglutide is dosed and taken
Semaglutide for weight loss is deliberately started low and built up. The weekly injection begins at 0.25mg and steps up roughly every four weeks through 0.5mg, 1.0mg and 1.7mg towards the 2.4mg maintenance dose. The first pen isn't there to treat you; its job is to let your system settle so nausea is less likely. Your prescriber, not a fixed timetable, decides when and whether to move up.
In January 2026 the MHRA approved a higher 7.2mg maintenance dose, and in April 2026 approved a dedicated single-dose 7.2mg pen for adults with a BMI of 30 or above. Whether a specific dose or pen format is available to you is confirmed at consultation rather than assumed in advance. Our overview of Wegovy dosing steps walks through the ladder.
The injection goes under the skin of the abdomen, thigh or upper arm, and you rotate the site each week. It's stored in the fridge, and there's a limited window it can spend at room temperature, so always follow the exact figures in the patient information leaflet rather than a number from a webpage. Many people find timing the injection to a quiet day of the week helps them remember it; there's more on that in timing your Wegovy dose.
The oral tablet works differently in practice: once daily, first thing, on an empty stomach with a small sip of water, then at least 30 minutes before food, drink or other tablets. We never give you a personal dose plan on a webpage. That's a prescriber's job, guided by the SmPC.
What the trials found semaglutide can do for weight
The headline evidence for the weekly injection comes from the STEP 1 trial, published in the New England Journal of Medicine. Over 68 weeks, adults taking the 2.4mg dose alongside diet and activity lost around 15% of their body weight on average. That's a meaningful clinical result, and it's why semaglutide became such a talked-about treatment.
Newer data pushes the numbers further. The 7.2mg dose reported around 20.7% average weight loss over 72 weeks in trials, bringing semaglutide close to the results seen with tirzepatide. For the oral tablet, the OASIS 4 trial in adults with obesity or overweight plus a weight-related condition found roughly 13.6% average weight loss over 64 weeks against placebo, rising to about 17% among participants who stayed fully adherent to treatment.
A few caveats keep this honest. These are trial averages, so individual results vary widely, and the figures assume the lifestyle changes the licence requires. Weight also tends to return if treatment stops without a plan, because the underlying biology doesn't change. Weight is a health condition shaped by physiology, not a failure of willpower, and semaglutide treats one part of that picture rather than all of it.
If you want the lived-experience angle rather than the trial data, our collection of Wegovy reviews and the broader semaglutide for weight loss page put the numbers in context without overselling them. The NICE appraisal of semaglutide (TA875) is the formal UK verdict.
Side effects and when semaglutide isn't suitable
The most common side effects are gastrointestinal: nausea, an unsettled stomach, diarrhoea or constipation, reflux, burping, and sometimes tiredness, headache or dizziness. They're usually most noticeable in the first days after starting or after a dose increase, and for many people they ease within a couple of weeks as the body adjusts. Starting low and going slow is designed to keep them manageable.
There are rarer but serious risks to take seriously. In January 2026 the MHRA issued a Drug Safety Update flagging acute pancreatitis as an uncommon but potentially serious effect of GLP-1 medicines. The warning sign to act on is severe, persistent stomach pain that may spread through to your back, with or without vomiting. If that happens, seek urgent medical help. Suspected side effects can be reported through the MHRA Yellow Card scheme.
Semaglutide isn't for everyone. It isn't recommended in pregnancy or while breastfeeding, and it isn't used if you're trying to conceive; it isn't licensed for under-18s either. A history of pancreatitis, certain thyroid cancers or particular gut conditions all need a proper conversation with a prescriber before anything is prescribed. Contraception matters too: the MHRA advises using contraception on GLP-1 medicines and allowing a wash-out period before trying for a baby, though NHS guidance notes there's no evidence semaglutide reduces pill effectiveness in the way tirzepatide can.
This is exactly why the assessment exists. A safe prescription isn't a formality; it's the part that catches the reasons this medicine might not be right for you.
Getting semaglutide on the NHS versus privately
The NHS does prescribe semaglutide for weight management, but access is tightly controlled. Under NICE TA875 it's offered through specialist weight management services, for a maximum of two years, to adults who meet a high BMI threshold (usually 35, or lower for some ethnic backgrounds) with a weight-related condition. Demand far outstrips capacity, so waiting lists for those services are commonly long.
Private treatment through a regulated online pharmacy is the alternative for people who don't meet the NHS criteria or don't want to wait years. It's the same medicine and the same regulator standing behind it; the difference is the route, not the drug. You still need a genuine clinical assessment, and you should still only use a pharmacy you can verify on the GPhC register. Our guide to getting Wegovy online safely covers what to check.
On cost, semaglutide is priced per pen or per month and varies between providers, and any legitimate price should include the prescription and clinical assessment behind it. We're deliberately not the cheapest option, and we're comfortable saying so; for a prescription medicine, the lowest listing usually answers the wrong question. What matters more is genuine supply, real clinical oversight and support if something goes wrong. Our Wegovy pricing in the UK page sets out the market context, and the NHS England guidance on weight-management injections explains the NHS pathway in full.
Cheapest is easy to Google. Safe and legitimate takes a little more checking. It's worth it.
Related questions we've answered
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.